| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/24/2008 | US20080175894 Methods of treating neurological conditions with hematopeitic growth factors |
| 07/24/2008 | US20080175883 Self-assembling peptide amphiphiles |
| 07/24/2008 | US20080175878 Protease for activating clotting factor VII |
| 07/24/2008 | US20080175876 Novel Chitinase and Uses Thereof |
| 07/24/2008 | US20080175871 Eliciting improved immune responses |
| 07/24/2008 | US20080175866 involved in the adaptation of microorganisms to its environment, particularly the identification of genes responsible for the virulence of a pathogenic microorganisms |
| 07/24/2008 | US20080175855 Containing one or more epitopes recognized by and binding to a BAT monoclonal antibody; cancer vaccines |
| 07/24/2008 | US20080175854 Point mutations; antibodies; fusion proteins |
| 07/24/2008 | US20080175853 Virus-like particles for the induction of autoantibodies |
| 07/24/2008 | US20080175849 Monoclonal antibody for use in diagnosis, prevention and treatment of infectious mononucleosis and cell proliferative disorders |
| 07/24/2008 | US20080175848 Reducing matrix protein concentration via enzyme inhibitor and plasmin administration; prevention and treatment of fibrosis; wound healing agent |
| 07/24/2008 | US20080175845 Using tumor necrosis factor receptor specific monoclonal antibody as therapeutic for treatment and prevention of inflammatory disorders |
| 07/24/2008 | US20080175843 Nucleotide sequences coding osteoblast activating factor (OAF) for use in diagnosis, prevention and treatment of inflammatory, periodontal and infectious diseases |
| 07/24/2008 | US20080175842 Compositions and methods for treatment |
| 07/24/2008 | US20080175840 Methods for treating angiogenesis related disorders |
| 07/24/2008 | US20080175837 Autophagy regulators; drug screening; dipeptidyl peptidase IV (Dpp4); preservative of organs for transplantation |
| 07/24/2008 | US20080175834 Carboxypertidase U (Cpu) Mutants |
| 07/24/2008 | US20080175833 Using alpha -glucosidase administration to treat defects in glycogen synthesis or breakdown within muscles, liver and other cell types |
| 07/24/2008 | US20080175832 Materials and Methods for Prevention and Treatment of RNA Viral Diseases |
| 07/24/2008 | US20080175831 Neuroprotection by blood flow stabilization |
| 07/24/2008 | US20080175820 Using vascular endothelial growth factor as wound healing agent; tissue engineering; regenerative medicine; wound healing agent |
| 07/24/2008 | US20080175818 Using replication-defective plasmid comprising p53 nucleotide sequences as as delivery tool for antitumor agents |
| 07/24/2008 | US20080175815 Using macrophage migration inhibitory factor gene expression profile as predictive tool evaluating fertility and endometrial disorders |
| 07/24/2008 | US20080175814 Quinoline derivatives for modulating dna methylation |
| 07/24/2008 | CA2676340A1 Methods of use of epsilon inhibitor compounds for the attenuation of pain |
| 07/24/2008 | CA2675813A1 Specific therapy and medicament using integrin ligands for treating cancer |
| 07/24/2008 | CA2675754A1 Mutated netrin 4, fragments thereof and uses thereof as drugs |
| 07/24/2008 | CA2675753A1 Substance p and analogs thereof as an immunogenic composition adjuvant |
| 07/24/2008 | CA2675665A1 Modifications of peptide compositions to increase stability and delivery efficiency |
| 07/24/2008 | CA2675233A1 Methods for treating psoriasis |
| 07/24/2008 | CA2675157A1 Fibrin gel for controlled release of tgf-beta and uses thereof |
| 07/24/2008 | CA2674445A1 Gp100-specific t cell receptors and related materials and methods of use |
| 07/24/2008 | CA2673765A1 Enhanced cell-free synthesis of active proteins containing disulfide bonds |
| 07/24/2008 | CA2673516A1 Method of purifying apolipoprotein a-1 |
| 07/24/2008 | CA2672091A1 Disintegrin variants and pharmaceutical uses thereof |
| 07/24/2008 | CA2667678A1 Toxin peptide therapeutic agents |
| 07/24/2008 | CA2661651A1 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| 07/24/2008 | CA2659858A1 Liposome treatment of viral infections |
| 07/23/2008 | EP1947187A1 Hybrid expression of neisserial proteins |
| 07/23/2008 | EP1947185A1 HCV NS3/4A encoding nucleic acid |
| 07/23/2008 | EP1947183A1 Mammalian cell surface antigens; related reagents |
| 07/23/2008 | EP1947182A1 Fibroblast growth factor-23 molecules and uses thereof |
| 07/23/2008 | EP1947175A1 Sequence of nucleotides and peptides gse 24.2 of dyskerin, which can induce telomerase activity, method for obtaining same, therapeutic compositions and applications thereof |
| 07/23/2008 | EP1947174A1 Chimeric human papillomavirus (HPV) L1 molecules and uses therefor |
| 07/23/2008 | EP1947119A2 Treatment of cancer with anti-erb2 antibodies in combination with a chemotherapeutic agent |
| 07/23/2008 | EP1947118A1 VEGF traps and therapeutic uses thereof |
| 07/23/2008 | EP1947117A2 Glycoprotein hormone superagonists |
| 07/23/2008 | EP1947116A2 Differentially expressed nucleic acids in the blood-brain barrier under inflammatory conditions |
| 07/23/2008 | EP1947115A2 Combination of glycoisoforms for the treatment or prevention of septicemia, transgenic cell line that produces erythropoietin glycoisoforms, pharmaceutical composition comprising said combination, method of obtaining the cell line, method of producing the combination of glycoisoforms and methods for the treatment and preven |
| 07/23/2008 | EP1947114A1 Mutated netrin 4, fragments thereof and uses thereof as drugs |
| 07/23/2008 | EP1947113A1 P53 binding polypeptide |
| 07/23/2008 | EP1947112A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 07/23/2008 | EP1947111A1 Novel mucin glycoprotein and use thereof |
| 07/23/2008 | EP1947109A2 Biologically active peptides |
| 07/23/2008 | EP1947106A1 Streptococcus pneumoniae methionyl tRNA synthetase |
| 07/23/2008 | EP1946776A1 Stabilized TNFR-Fc composition comprising arginine |
| 07/23/2008 | EP1946775A2 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody |
| 07/23/2008 | EP1946768A1 Outer coat protein pa5158 of pseudomonas aeruginosa |
| 07/23/2008 | EP1946766A1 Reproductive disorder remedy |
| 07/23/2008 | EP1946765A1 Remedy for angiogenesis-related disease comprising chondromodulin-i as the active ingredient |
| 07/23/2008 | EP1946764A1 Nutrient composition |
| 07/23/2008 | EP1946749A1 Anti-angionene compositions and methods of use |
| 07/23/2008 | EP1946120A2 Mtor pathway theranostic |
| 07/23/2008 | EP1945819A2 Gene expression profiles and methods of use |
| 07/23/2008 | EP1945790A2 Vasoactive intestinal polypeptide pharmaceuticals |
| 07/23/2008 | EP1945783A2 Modulation of il-2 production by t-bet |
| 07/23/2008 | EP1945663A1 Insulin-like growth factor ii (igf-ii) binding factors |
| 07/23/2008 | EP1945661A1 Gpr 146 receptor |
| 07/23/2008 | EP1945658A2 Diastereomeric peptides for modulating t cell immunity |
| 07/23/2008 | EP1945266A1 Methods of modulating apoptosis and platelet production using variants of cytochrome c |
| 07/23/2008 | EP1945263A2 Metal-binding therapeutic peptides |
| 07/23/2008 | EP1945261A2 Compositions and methods for controlling tissue factor signaling specificity |
| 07/23/2008 | EP1945259A2 Fusion proteins for blood-brain barrier delivery |
| 07/23/2008 | EP1945258A2 Tdf-related compounds and analogs thereof |
| 07/23/2008 | EP1945256A1 Methods and compositions for modulating wound repair |
| 07/23/2008 | EP1945244A2 Pharmaceutical compositions and diagnostic methods for inflammatory skin disesaes, disorders or conditions |
| 07/23/2008 | EP1945243A1 Use of calcitonin for the treatment of ra |
| 07/23/2008 | EP1945242A2 Inhibition of extracellular signal-regulated kinase 1/2 as a treatment for cardiac hypertrophy and heart failure |
| 07/23/2008 | EP1945241A2 Treatment of proliferative disorders withpolycationic agents |
| 07/23/2008 | EP1945240A2 Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof |
| 07/23/2008 | EP1945204A2 V-atpase inhibitors for use in the treatment of septic shock |
| 07/23/2008 | EP1945201A2 Calcium receptor activator |
| 07/23/2008 | EP1945200A2 Composition useful for the recovery of the original trophism and pigmentation and for stimulating the growth of the tegumentary apparatuses, use thereof and products |
| 07/23/2008 | EP1945199A1 Leucine rich composition |
| 07/23/2008 | EP1907419A4 Preparation of insulin conjugates |
| 07/23/2008 | EP1796725B1 Treatment or prevention of unscheluded bleeding in women on progestogen containing medication |
| 07/23/2008 | EP1441757B1 Non-neurotoxic plasminogen activating factors for treating stroke |
| 07/23/2008 | EP1401426B1 Ptpase inhibitors and method of using same |
| 07/23/2008 | EP1372696B1 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 07/23/2008 | EP1356030B1 Runx3 gene showing anti-tumor activity and use thereof |
| 07/23/2008 | EP1335742B1 Use of peptides dervied from apoB100 in the production of a vaccine/diagnostic against atherosclerosis |
| 07/23/2008 | EP1328287B1 Compositions and methods for wt1 specific immunotherapy |
| 07/23/2008 | EP1278829B1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 07/23/2008 | EP1272167B1 Ropinirole-containing hydrophilic/liphilic polymeric matrix dosage formulation |
| 07/23/2008 | EP1181036B1 Pharmaceutical compositions of erythropoietin |
| 07/23/2008 | EP1123383B1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 07/23/2008 | EP1085876B1 Pharmaceutical composition with tumor necrosis factor a and 2-methoxyestrone-3-o-sulphamate for inhibition of estrone sulphatase |
| 07/23/2008 | EP1032688B1 Single-chain bifunctional glycoprotein hormones |
| 07/23/2008 | EP0981617B1 Recombinant lactoferrin, methods of production from plants and uses |
| 07/23/2008 | EP0970206B1 Lage-1 tumor associated nucleic acids |